RecruitingNot ApplicableNCT07184541

A Nurse-Led Weight Monitoring Intervention For Heart Failure Quality of LIfe and Self-Care

The Effect of a Nurse-led Daily Weight Monitoring Intervention (Wake and Weigh) on Heart Failure Quality of Life and Self-care


Sponsor

Lee Anne Siegmund

Enrollment

42 participants

Start Date

Nov 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Ongoing self-care for heart failure is essential to avoid complications and hospitalization. Supportive strategies are needed; however, patients with heart failure may find many interventions complicated and overwhelming. The purpose of this pilot study is to implement a simple weight tracking tool (Wake and Weigh) to affect self-care and quality of life in a population of older adults with heart failure. This will be a randomized controlled pilot trial to test the methods to be used in a larger randomized controlled trial. The Self-care in Heart Failure Index and Kansas City Cardiomyopathy Questionnaire surveys will be given at admission and four weeks after discharge. The Wake and Weigh tool is designed to help patients track weight in the hospital and following discharge. Feasibility endpoints will be summarized descriptively.


Eligibility

Min Age: 55 Years

Inclusion Criteria6

  • Adults (55 years or older)
  • New or existing diagnosis of HF (regardless of type or length of time since diagnosis).
  • Being treated for HF signs and/or symptoms during the current hospitalization (any of the following: IV diuretic, fluid restriction, low sodium diet).
  • Must be able to read and communicate in English.
  • Must be able to stand and weigh independently.
  • Must have a scale at home, or ability to obtain one for the study.

Exclusion Criteria2

  • Documented diagnosis of cognitive impairment.
  • A Charlson Comorbidity Index (CCI) of \>4. This was chosen to exclude patients more likely to have hospital stays longer than a week. A CCI of \>3 was based on research showing a relationship to mortality (Imam et al., 2020), a CCI of ≥ 6 with a 2.8-times higher mortality (Yilmaz \& Omurlu, 2019), and likelihood of longer hospital length of stay for patients with HF if CCI \>2 (Foraker et al., 2014).

Interventions

BEHAVIORALWake and Weigh

The Wake and Weigh tool includes the patient's dry weight and instructions for daily weight monitoring. Participants in the intervention group will be instructed on the use of the tool. While in the hospital, weight is being managed by the healthcare team, so the goal during hospitalization is to educate the patient on what to do once discharged, and to recognize changes in weight.

BEHAVIORALUsual care

The usual care group will receive the heart failure handbook that is routinely given to heart failure patients.


Locations(1)

Cleveland Clinic Avon Hospital

Avon, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07184541


Related Trials